Related Experiment Videos

Clinicobacteriological study of empyema thoracis in infants and children

S Ghosh1, C K Chakraborty, B D Chatterjee

  • 1RMO-cum-Clinical Tutor (Paediatric Medicine), Dr BC Roy Memorial Hospital for Children, Calcutta.

Insights

This study on pediatric empyema thoracis found Staphylococcus aureus as the main cause, often linked to malnutrition and anemia. Effective treatment involved antibiotics like gentamicin and cloxacillin with chest tube drainage.

Area of Science:

  • Pediatric infectious diseases
  • Thoracic surgery
  • Clinical microbiology

Background:

  • Empyema thoracis is a serious thoracic infection.
  • Pediatric cases present unique challenges in diagnosis and management.
  • Understanding causative agents and risk factors is crucial for effective treatment.

Purpose of the Study:

  • To investigate the clinical characteristics, aetiopathogens, and outcomes of empyema thoracis in pediatric patients.
  • To evaluate the effectiveness of current therapeutic strategies.

Main Methods:

  • Retrospective analysis of 41 pediatric empyema thoracis cases admitted between April 1985 and August 1987.
  • Microbiological investigations to identify causative pathogens.
  • Assessment of patient demographics, clinical presentation, treatment protocols, and outcomes.

Main Results:

  • The majority of patients were male (65.9%) and under 2 years old (70.7%).
  • Staphylococcus aureus was the predominant pathogen (68.3%), with resistance to penicillin and ampicillin but sensitivity to gentamicin, cloxacillin, and erythromycin.
  • High rates of malnutrition (73.2%) and anemia (53.7%) were observed. Mortality was 17.1%.

Conclusions:

  • Staphylococcus aureus is a primary cause of pediatric empyema thoracis, necessitating targeted antibiotic therapy.
  • Malnutrition and anemia are significant comorbidities, impacting patient outcomes.
  • Prompt management with antibiotics and chest tube drainage is essential, with an average hospital stay of 15.8 days.

Related Concept Videos